Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients. - Wikidata - wikimedia - TriplyDB

Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.

Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.

http://www.wikidata.org/entity/Q37496863

about

T1-weighted dynamic contrast-enhanced brain magnetic resonance imaging: A preliminary study with low infusion rate in pediatric patients.

P2860

Q50615683-B88E26B8-8163-4F22-BC69-7DE5B1F08243

P2860

Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.

http://www.wikidata.org/entity/Q37496863

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic value of preoperati ...... or high-grade glioma patients.

@en

Prognostic value of preoperati ...... or high-grade glioma patients.

@nl

type

label

Prognostic value of preoperati ...... or high-grade glioma patients.

@en

Prognostic value of preoperati ...... or high-grade glioma patients.

@nl

prefLabel

Prognostic value of preoperati ...... or high-grade glioma patients.

@en

Prognostic value of preoperati ...... or high-grade glioma patients.

@nl

P1433

Q37496863-390ACFA7-43C6-4CDB-B54A-38064BB7C2CA

P1476

Q37496863-39AF0315-6FD4-4BA5-84FB-6C2188C09F5E

P2093

Q37496863-0630CAA2-9172-4CA4-94A1-5D14665E302B

Q37496863-35BD92C8-604F-4715-9EA2-920AF663D9AA

Q37496863-7170867B-0EA1-4188-8C2F-891D0B989664

Q37496863-92EE943E-891F-4F86-9CB2-6DAD3C9FF0AF

Q37496863-C72CB805-D293-4485-B179-2B4C2CC05407

P2860

Q37496863-019C432A-CC50-4FFD-8D36-B67825345E96

Q37496863-02342BC1-4A21-44FE-AF43-76F417577ED7

Q37496863-0FC5321A-400E-43E4-BB1F-FE6F2EF94FE0

Q37496863-14E61BFB-7F20-4A59-BB1A-F63B96429219

Q37496863-177C8ADB-40DB-420C-9510-E3ABB0974E0B

Q37496863-1EE6744D-1D62-4054-94D9-2F0AA210FF74

Q37496863-2398F371-516E-499F-BB8C-07FB88B2788A

Q37496863-2B5B58F4-CEA5-43E9-9EF6-A46917BF77A3

Q37496863-326F6104-0CEC-4CD6-9872-164BE5CA78CF

Q37496863-35BCFF15-1795-484B-8999-993AFAE370FA

P2888

Q37496863-F8C5C79C-3622-4607-9B9F-C2CDB30D486D

P304

Q37496863-DFFC4E9F-5C40-4AA8-AE29-ADB8422B2C25

P31

Q37496863-BB3B08E4-F22E-4141-BE3F-B0EEF4100912

P356

Q37496863-76375FDE-1A81-4EB4-A6DD-4B97E769BB95

P433

Q37496863-C496F12E-84E9-4AF4-BDD0-FC61A2CFB839

P478

Q37496863-B18E458C-2F9A-46FA-97E2-33E3BB427A7C

P50

Q37496863-108DAB69-1BC2-4DF4-9403-54389A70170A

Q37496863-1B6DE6B3-517D-4FD5-8907-E8E2180D1C92

Q37496863-91CB2C87-5AC6-4E58-A968-3BEE51E66671

P577

Q37496863-8D7B4E28-5EA8-4975-BD1E-9E18C3392DBA

P698

Q37496863-1E7BD138-956C-48AC-884A-6C71260A5B66

P932

Q37496863-68B0E92D-BBA1-45C8-880A-EE0B0218D01C

P356

S00234-016-1741-7

P1433

P1476

Prognostic value of preoperati ...... for high-grade glioma patients

@en

P2093

Agne Ulyte

http://www.w3.org/2001/XMLSchema#string

Christos Boskos

http://www.w3.org/2001/XMLSchema#string

Evangelia Liouta

http://www.w3.org/2001/XMLSchema#string

Georgios Stranjalis

http://www.w3.org/2001/XMLSchema#string

Jurgita Usinskiene

http://www.w3.org/2001/XMLSchema#string

P2860

IDH1 and IDH2 mutations in gliomas

Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic review

Improving tumour heterogeneity MRI assessment with histograms.

Malignant gliomas in adults

Do imaging biomarkers relate to outcome in patients treated with VEGF inhibitors?

Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach.

Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging.

Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas.

The MRI measurement of NMR and physiological parameters in tissue to study disease process.

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

P2888

s00234-016-1741-7

P304

1197-1208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00234-016-1741-7

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Sotirios Bisdas

P577

2016-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27796446

http://www.w3.org/2001/XMLSchema#string

P932

5153415

http://www.w3.org/2001/XMLSchema#string